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Abstract
Epidemiological studies have revealed that offspring conceived by in vitro fertilization (IVF) have an
elevated risk of cardiovascular malformations at birth, and are more predisposed to cardiovascular
diseases. The renin-angiotensin system (RAS) plays an essential role in both the pathogenesis
of congenital heart disease in fetuses and cardiovascular dysfunction in adults. This study aimed
to assess the relative expression levels of genes in the RAS pathway in mice conceived using
IVF, compared to natural mating with superovulation. Results demonstrated that expression of
the angiotensin II receptor type 1 (AGTR1), connective tissue growth factor (CTGF), and collagen
3 (COL3), in the myocardial tissue of IVF-conceived mice, was elevated at 3 weeks, 10 weeks,
and 1.5 years of age, when compared to their non-IVF counterparts. These data were supported by
microRNA microarray analysis of the myocardial tissue of aged IVF-conceived mice, where miR-100,
miR-297, and miR-758, which interact with COL3, AGTR1, and COL1 respectively, were upregulated
when compared to naturally mated mice of the same age. Interestingly, bisulfite sequencing data
indicated that IVF-conceived mice exhibited decreased methylation of CpG sites in Col1. In support
of our in vivo investigations, miR-297 overexpression was shown to upregulate AGTR1 and CTGF,
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and increased cell proliferation in cultured H9c2 cardiomyocytes. These findings indicate that the
altered expression of RAS in myocardial tissue might contribute to cardiovascular malformation
and/or dysfunction in IVF-conceived offspring. Furthermore, these cardiovascular abnormalities
might be the result of altered DNA methylation and abnormal regulation of microRNAs.
Summary Sentence
Altered expression of the renin-angiotensin system in myocardial tissue might contribute to an
increased risk of cardiovascular malformations and dysfunction in IVF offspring, and is involved in
abnormal regulations of DNA methylation and microRNAs.
Key words: DNA methylation, in vitro fertilization, mouse, myocardium, renin-angiotensin system, microRNA.
Introduction
Since the birth of Louise Brown, the first baby conceived via in
vitro fertilization and embryo transfer (IVF-ET) in 1978, more than
5 million newborns have been conceived through assisted repro-
ductive technology (ART) [1, 2]. ART includes controlled ovarian
hyperstimulation, IVF-ET, intracytoplasmic sperm injection (ICSI),
preimplantation genetic diagnosis, and gamete and embryo cryop-
reservation. The clinical implementation of ART has made a signifi-
cant contribution to the treatment of infertility [3]. However, ART
intervenes several key points during the process of human concep-
tion and early development, specifically gametogenesis, fertilization,
and early embryonic maturation. Data has shown that during the
periconceptional period, the oocyte and embryo are highly sensitive
to signals from their surrounding environment and as such, are par-
ticularly susceptible to damage which might manifest in an altered
adult phenotype [4]. Follow-up studies on the growth and develop-
ment of ART-conceived human offspring have aroused widespread
concern as their findings indicate that when compared with natu-
rally conceived newborns those conceived by IVF are at greater risk
of low birth weight, increasing their susceptibility in adulthood to
cardiovascular disease and diabetes [5–7]. These data are of partic-
ular concern given the extensive clinical application of ART and a
large number of resultant ART-conceived offspring [8]. Multicenter
epidemiological studies have shown that the incidence of cardio-
vascular malformations in ART babies is markedly increased com-
pared with that of naturally conceived offspring [9–11]. Further-
more, follow-up surveys of ART-conceived offspring have shown an
increased risk of dysfunction [12] and remodeling in the cardiovas-
cular system [13], including higher arterial blood pressure, altered
vascular intima-media thickness, and compromised myocardial reg-
ulatory function [14]. Investigations using mouse models have fur-
ther illustrated that ART-conceived offspring have abnormal vascu-
lar endothelial function and changes in lipid metabolism [15, 16].
While it is widely accepted that IVF-conceived offspring have an in-
creased risk of poor cardiovascular health, the precise mechanisms
underlying cardiovascular malformation and dysfunction remain
unclear.
The renin-angiotensin system (RAS) is a major physiological sys-
tem that regulates blood pressure and the balance of fluids and elec-
trolytes within the body. In addition, the RAS is known to play an
essential role in the pathogenesis of several types of cardiovascular
disease as well as in cardiac remodeling [17, 18]. Growing evidence
reveals that in addition to the classic systemic RAS, a local RAS
operates, in organs such as the heart, large arteries, kidneys, and
even in single cells to further modulate cardiovascular regulation
[19, 20]. In the RAS, the precursor protein angiotensinogen (AGT)
is first converted into angiotensin I (Ang I) by renin (Ren). Then,
Ang I is hydrolyzed to Ang II-IX by angiotensin-converting enzymes
(ACE). Ang II is a biological key hormone, and its function is medi-
ated through the receptors of Ang II type 1 (AGTR1) or Ang II type
2 (AGTR2) [21]. Excessive activation of AGTR1 results in increased
expression levels of the extracellular matrix components, such as col-
lagen 1 (COL1) and collagen 3 (COL3) [22], which are distributed
in several layers of the heart wall to provide rigidity and elasticity
[23]. During the embryonic period, abnormal expression of COL1
and COL3 can affect the normal development of the cardiovascular
structures [24, 25]. In adulthood, overstimulation of the RAS can
contribute to the pathogenesis of a number of cardiovascular dis-
eases, affecting the normal function of cardiovascular tissue cells and
increasing the risk of hypertension, heart arrhythmias, and cardiac
hypertrophy [26]. Connective tissue growth factor (CTGF) promotes
fibrosis therefore playing a further key role in AT1-mediated intra-
cellular signal transmission that results in myocardial remodeling
and vascular fibrosis [27].
During gametogenesis and early embryogenesis, parental
genomes undergo demethylation and remethylation for epigenetic
reprogramming. The first round of genome reprogramming occurs
in the germline, while the second round of genome reprogramming
occurs after fertilization when somatic methylation patterns are gen-
erated [28]. Evidence suggests that the early embryo, and later the
fetus, is highly sensitive to its in utero environment, and that a sub-
optimal uterine milieu, such as is experienced by the fetus during ma-
ternal nutritional restriction, could increase the incidence of chronic
diseases in adulthood via epigenetic modifications in the embryo or
fetus [4, 29, 30]. Since IVF-ET overlaps with the epigenetic repro-
gramming period of the embryo, the risk of imprinting defects that
cause imprinted disorders such as Prader-Willi syndrome and Angel-
man syndrome may increase when fertilization and early embryonic
development occur in vitro [31]. Recent experiments in humans and
mice have revealed differences in the methylation levels of CpG is-
lands in imprinting genes and developmentally important genes be-
tween ART-conceived offspring and control groups [32, 33]. A pre-
vious study from our research group showed alterations in Igf2/H19
expression and DNA methylation in both the liver and the skele-
tal muscle of IVF mice [34]. Interestingly, ICSI-conceived fetuses
also exhibit a decreased rate of CpG island methylation, accom-
panied by increased expression of insulin-induced gene 1 (INSIG1)
and resulting in significantly increased umbilical cord blood lipid
levels [35]. In addition to ART-associated DNA methylation and
chromatin acetylation modifications, the role of noncoding RNAs in
regulating gene expression has become a concern in IVF-ET off-
spring [36]. It is known that multiple microRNAs (miRNAs) are in-
volved in the regulation of hypertension, coronary heart disease, and
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glycolipid metabolic disorders [37, 38]. However, few studies have
focused on whether ART affects the expression of miRNAs. There-
fore, a miRNA array was performed in this present study to identify
associations between miRNA expression and the use of IVF-ET,
and also to explore possible miRNA mediated mechanisms influ-
encing the increased incidence of cardiovascular disease in ART
offspring.
Variations in the health status diseases, fertility, genetic back-
ground, and living environment of human patients make it difficult
to clarify a causal link between the use of ART and the develop-
ment of cardiovascular aberrations in offspring. In addition, it is
currently almost impossible to assess the long-term health of a pop-
ulation conceived through ART, since most IVF-conceived offspring
are less than 30 years old. Therefore, a mouse model was used in
this study to evaluate the expression levels of RAS components in
the myocardial tissue of IVF and naturally conceived mice, from
3 weeks to 1.5 years. In addition, corresponding DNA methylation
levels in the RAS, and miRNA expression profiles were evaluated,
with the view to investigate the presence of underlying epigenetic reg-
ulatory mechanisms that might influence cardiovascular dysfunction
in ART-conceived offspring.
Materials and methods
Experimental animals
All treatment protocols were approved by the Animal Care Ethics
Committee of Zhejiang University (No. ZJU2009101007Y). The
methods used in these investigations were performed in accordance
with the approved guidelines. C57BL/6J female mice (6–8 weeks old)
and male mice (10–12 weeks old) were used in this study. All animals
were provided with nesting materials and housed with a constant
12-h light/12-h dark cycle at 25◦C ± 0.5◦C with 50%–60% humid-
ity. Mice were fed standard chow and water.
Experimental design
All female mice were superovulated and randomly divided into the
IVF group and the in vivo naturally mated group.
Superovulation
C57BL/6J female mice were injected intraperitoneally with 7.5 IU
(0.15 ml) of pregnant mare serum gonadotropin (PMSG) (GEN’s,
Hangzhou, China). After 48 h, the female mice were injected with
7.5 IU (0.15 ml) of human chorionic gonadotropin (hCG) (GEN’s).
In vitro fertilization
Human tubal fluid (HTF) (Irvine Scientific, CA, USA) medium con-
taining 10% synthetic serum substitute (SSS; Irvin Scientific) was
equilibrated at 37◦C with 5% CO2 and 95% humidity overnight be-
fore IVF. In the IVF group, sperms were collected from the cauda epi-
didymis of C57BL/6J male mice in warmed modified HTF (mHTF)
(containing 10% SSS) (Irvine Scientific) and then transferred to
freshly warmed HTF for capacitation. Capacitation of the sperma-
tozoa was performed in a 37◦C environment with 5% CO2 and
95% humidity for 1–2 h. C57BL/6J female mice were euthanized by
cervical dislocation at 15 h after hCG injection. The oviducts were
separated and placed in warmed mHTF, and the ampulla of the fal-
lopian tube was punctured. Cumulus-oocyte complexes were washed
twice in mHTF and then transferred to HTF droplets. The capaci-
tated sperm suspension was gently added to the HTF medium with
metaphase II oocytes in a final sperm concentration of 1–2× 106/ml.
Sperm and oocytes were co-cultured for 6 h in the insemination
medium. Then, the presumptive embryos were gently washed twice
for further culture in fresh HTF. The two-cell-stage embryos of the
IVF group were obtained 24 h later.
In the in vivo group, C57BL/6J female mice were caged with
male mice at a ratio of 1:1 after hCG injection. The next day,
female mice with a vaginal plug were separated from the males.
After 44 h of hCG injection, the female mice were euthanized by
cervical dislocation and two-cell embryos were obtained from the
oviducts. The operating conditions were the same as those of the IVF
group.
Embryo transfer
Female mice at least 8 weeks of age from the Institute of Cancer
Research (ICR) were used as pseudopregnant recipients. Vaginal
plugs were detected the morning after mating with vasectomized
males from the ICR, and the animals were considered to be at
day 0.5 of pseudopregnancy. Twelve morphologically normal two-
cell-stage embryos in each group were transferred to the oviducts of
pseudopregnant recipients.
Postnatal growth
The birth outcomes of mice were described previously [34]. Fifty-one
mice were born in each of the IVF and in vivo groups. No significant
differences were observed in pregnancy rate, birth rate, mortality,
or sex ratio. The wet weights of mice were recorded weekly from
birth to 10 weeks of age, and biweekly from 11 weeks to 1.5 years
of age. The animals were euthanized, and the myocardial tissue was
dissected. A part of the tissue was snap frozen in liquid nitrogen and
stored at 80◦C for RNA, DNA, and protein detection. The remaining
tissue was fixed overnight with 4% paraformaldehyde in phosphate-
buffered saline (PBS) for immunohistochemistry.
Cell culture
The H9c2 (2–1) cell line was purchased from American Type Cul-
ture Collection (ATCC, MD, USA) and cultured in Dulbecco mod-
ified Eagle’s medium (DMEM) (Life Sciences, UT, USA) containing
10% fetal bovine serum (FBS) (Gibco, NY, USA) and 1% peni-
cillin/streptomycin solution (Gibco) in 100-cm2 flasks at 37◦C in a
humidified atmosphere of 5% CO2.
MicroRNA transfection
The H9c2 cells in the exponential phase of growth (2 × 105/well)
were cultured overnight in six-well plates to overexpress miR-297.
The cells were transfected with a miR-297 mimic (100 nM) or neg-
ative control RNA (100 nM) using the riboFECT CP reagent and
buffer (RiboBio) according to the manufacturer’s protocol. First,
10 μl of miRNAs was diluted with 120 μl of riboFECT CP buffer
for 10 min at room temperature. This diluent was mixed with 12
μl of riboFECT CP reagent and incubated for 10 min at room tem-
perature. Finally, the total mixture was added to each well of the
plate together with 1.8 ml of DMEM and incubated at 37◦C. RNA
and protein was extracted from the H9c2 cells after 24 and 48 h,
respectively.
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RNA extraction
Total RNA was extracted from the myocardial tissue of mice and
H9c2 cells after transfection according to the manufacturer’s proto-
col using the RNAiso Plus kit (TaKaRa, Tokyo, Japan).
Reverse transcription
For mRNAs (Ren1, Ace, Ace2, Agt, Agtr1a, Agtr1b, Agtr2a, Col1a1,
Col1a2, Col3, Ctgf), 0.5-μg RNA samples were reverse-transcribed
with PrimeScript RT Reagent Kit (TaKaRa). For miRNAs (miR-
100, miR-297, miR-758), reverse transcription was performed with
Mir-X microRNA FirstStrand Synthesis Kit (TaKaRa). U6 snRNA
controls served as a reference gene for analyzing microRNA expres-
sion levels.
Real-time quantitative polymerase chain reaction
Real-time quantitative polymerase chain reaction (PCR) analysis was
performed using SYBR Premix Ex Taq (TaKaRa) for mRNAs and
SYBR Premix Ex Taq II for miRNAs in an ABI 7900 thermocycler
(Applied Biosystems, CA, USA). Gapdh served as a reference gene
for analyzing gene expression levels. The real-time PCR data were
analyzed using the 2−CT method. The primers were synthesized by
Sangon (Shanghai, China). The primer sequences for real-time PCR
are shown in Supplementary Tables S1 and S2.
Western blotting
Myocardial tissues and H9c2 cells were homogenized in radioim-
munoprecipitation assay lysis buffer (CWBIO, Beijing, China), in-
cubated on ice for 20 min, and centrifuged at 14,000 g for 10 min
at 4◦C. The supernatant was transferred to a tube, and concentra-
tions were detected using the Bradford assay (Bio-Rad Laboratories,
CA, USA). Then, 50 μg of protein was transferred to each lane
on a 10% SDS-polyacrylamide gel. These samples were transferred
to polyvinylidene fluoride membranes (Millipore, MA, USA) and
incubated with the following primary antibodies (Supplementary
Table S3): anti-renin antibody (sc-137252; Santa Cruz Biotech-
nology, California, USA); anti-angiotensin converting enzyme 1
antibody (ab11734; Abcam, Cambridge, UK); anti-angiotensin II
type 1 receptor antibody (ab124505; Abcam, Cambridge, UK);
anti-angiotensin II type 2 receptor antibody (ab92445; Abcam);
anti-collagen 3 antibody (ab7778; Abcam); anti-CTGF antibody
(ab6992; Abcam); and anti-glyceraldehyde 3 phosphate dehydroge-
nase (GAPDH) antibody (ab181602; Abcam) overnight at 4◦C. They
were incubated with fluorescent secondary antibodies (680 and 790
nm; Jackson, PA, USA) for 2 h during RT. The protein bands were
visualized using the Odyssey Imager (Li-Cor Biosciences, NE, USA).
The GAPDH protein levels were used as the control protein.
DNA methylation analysis
Targeted bisulfite sequencing
The process of targeted bisulfite sequencing was performed to ana-
lyze DNA methylation, as described in a previous study [39]. The
genomic DNA of myocardial tissue was extracted using the DNeasy
Blood and Tissue Kit (Qiagen, Hilden, Germany). Genome bisulfite
modification was performed using the EpiTect Bisulfite Kit (Qiagen)
according to the operation manual, and its products were used for
subsequent PCR amplification. Targeted sequences of primers are
shown in Supplementary Table S4. Furthermore, a 1-μl bisulfite-
converted DNA template was performed using the PCR program.
The PCR conditions were as follows: 3 min at 94◦C, 5 cycles of
30 s at 94◦C, 30 s at 55◦C, and 30 s at 72◦C (decrease of 0.5◦C in
each cycle); then, 30 cycles of 30 s at 94◦C, 30 s at 50◦C, and 30 s at
72◦C; and finally 72◦C for 5 min. The PCR products were performed
with end-repair, A-tailing, adaptor ligation, and clean-up according
to the recommendations of KAPA Biosystems (MA, USA). A PCR
program using Kapa Hifi DNA Polymerase (KAPA Biosystems) was
performed as follows: 3 min at 94◦C, 9 cycles of 30 s at 94◦C, 30 s at
62◦C, and 30 s at 72◦C. The sequencing of samples was performed
on the MiSeq System (Illumina, CA, USA) using 100-bp paired-end
reads.
The methylation levels of each CpG site were calculated using
the Bismark’s methylation extractor tool [40] and shown using R
scripts. Average methylation levels of the target regions and other
information were generated with the local Perl, Python, and Shell
scripts to compile counts of methylated and unmethylated reads at
each CpG site.
MicroRNA microarray and bioinformatic analysis
MicroRNA profiling was performed by RiboBio. The quality and
quantity of RNA were assessed using a Nanodrop spectrophotome-
ter (Thermo Scientific, Waltham, MA, USA). A260/A280 ≥1.5 and
A260/A230 ≥1 were acceptable RNA purity levels, whereas an
acceptable RNA integrity number (RIN) value was ≥5 using the
Agilent 2200 RNA assay (Agilent Technologies, Santa Clara, CA,
USA). gDNA contamination was detected using gel electrophore-
sis; 1 μg of total RNA was labeled with cy3 using the (Universal
Linkage System) ULS method and hybridization was performed us-
ing RiboArray miDETECT mouse array (RiboBio). After the data
were acquired, microRNA targets were predicted using the following
databases: TargetScan (http://www.targetscan.org), microRNA.org
(http://www.microrna.org), miRDB (http://www.mirdb.org/), and
CLIP (http://lulab.life.tsinghua.edu.cn/clipdb/).
Luciferase assay
The AGTR1 3′-UTR or AGTR1 3′-UTR mutant fragment was
amplified by PCR and inserted into the pmiR-RB-Report vector
(Guangzhou Ruibo Biotech Company, China) to generate a lu-
ciferase reporter vector. Co-transfection of 293T cells with the re-
combinant vectors alongside miR-297a-3p mimic or negative control
(NC) was performed with lipofectamine 2000 transfection reagent
(Invitrogen, USA), according to the manufacturer’s instructions. The
relative luciferase activity was measured using the Dual-Luciferase
Reporter Assay (Promega, USA). The reporter vector used was
hRluc, with hluc as the internal reference corrected fluorescence. All
transfection assays were performed in three independent biological
replicates.
Cell proliferation assay
H9c2 cells were transfected with miRNA mimics in six-well plates.
Forty-eight hours after cell transfection, 5-ethynyl-20-deoxyuridine
(EdU) (10 μM) was added to the cultures and cells were grown for
an additional 2 h.
For imaging analysis of cell proliferation, the cells were fixed
with 4% formaldehyde in PBS for 30 minutes. After labeling, H9c2
cells were assayed using the Cell-Light EdU Apollo 488 in vitro
imaging kit (RiboBio) according to the manufacturer’s protocol. The
proliferation rate was calculated after normalizing the number of
EdU-positive cells to that of DAPI-stained cells in five randomly
selected high power fields. Images were acquired under an FV1200
laser confocal microscopy (Olympus, PA, USA).
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FIGURE 1. The mRNA relative expression of genes in the RAS components and those related to myocardial remodeling in myocardial tissue in the in vivo and
IVF groups at (A) 3 weeks, (B) 10 weeks, and (C) 1.5 years. Ren1, Ace, Ace2, Agt, Agtr1a, Agtr1b, and Agtr2 were critical elements in the RAS. Col1a1, Col1a2, and
Col3 were the major components of the extracellular matrix of the heart and also crucial in the development of heart and myocardial remodeling. Ctgf promotes
the pathological process of fibrosis. The data are presented as mean ± standard error of the mean. The relative levels were calculated using the 2−CT method.
∗P < 0.05 and ∗∗P < 0.01, compared with the in vivo group; Student t-test (N, in vivo = 6, IVF = 6 in 3-week-old mice; N, in vivo = 6, IVF = 6 in 10-week-old mice;
and N, in vivo = 6, IVF = 6 in 1.5-year-old mice).
For flow cytometry analysis of cell proliferation, EdU (10 μM)
(Cell Light EdU Apollo 488 in vitro flow cytometry kit; RiboBio)
was added and the cells were cultured for an additional 2 h accord-
ing to the manufacturer’s protocol. H9c2 cells were resuspended
in PBS and centrifuged at 15,000 rpm for 5 min. H9c2 cells were
fixed in 4% paraformaldehyde and permeabilized with 0.5% Triton
X-100. H9c2 cells were resuspended in PBS cells. Then, they were
immunocytochemically stained with antibodies. The following tests
were performed using ACEA NovoCyte flow cytometry (ACEA, San
Diego, CA, USA).
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FIGURE 2. Western blot analysis of REN1, ACE1, AGTR1, AGTR2, CTGF, and COL3 in myocardial tissue in the in vivo and IVF groups at (A) 3 weeks, (B) 10 weeks,
and (C) 1.5 years of age. GAPDH was used as the internal control. Data are presented as mean ± standard error of the mean. ∗P < 0.05 and ∗∗P < 0.01 compared
with the in vivo group; Student t-test (N, in vivo = 4; IVF = 4 in 3-week-old mice; N, in vivo = 4; IVF = 4 in 10-week-old mice; and N, in vivo = 4; IVF = 4 in
1.5-year-old mice).
Statistical analysis
The experimental data were compared using the Student t-test
(version 19.0; SPSS, NY, USA) to perform statistical analyses
of the results of the two groups. The results were presented
as mean ± standard error of the mean. For all results, sta-
tistically significant differences were defined as P < 0.05 and
P < 0.01.
Results
IVF altered the expression of genes in the RAS
components and those related to myocardial
remodeling in myocardial tissue
The expression levels of genes in the RAS components and corre-
sponding effect genes were detected using quantitative RT-PCR to
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FIGURE 3. Schematic overviews of the CpG island regions of Col1a1 (A). The target sequences examined by targeted bisulfite sequencing were shown, and CpG
sites were underlined. Average DNA methylation levels for the whole regions of CpG islands and the mean methylation levels for the individual CpG site of
Col1a1 (B) in the in vivo and IVF groups at 3 weeks, 10 weeks, and 1.5 years. Data are presented as mean ± standard error of the mean. ∗P < 0.05 and ∗∗P < 0.01
compared with the in vivo group; Student t-test (N, in vivo = 6; IVF = 6 in 3-week-old mice; N, in vivo = 6; IVF = 6 in 10-week-old mice; and N, in vivo = 6; IVF = 6
in 1.5-year-old mice).
investigate the effect of IVF on the expression of essential genes
related to the health of the cardiovascular system (Figure 1). The
genes in the RAS components examined in this study included Ren1,
Ace, Ace2, Agt, Agtr1a, Agtr1b, and Agtr2. The corresponding ef-
fect genes of the RAS included Col1a1, Col1a2, Col3, and Ctgf. At
3 weeks of age, the expression levels of Ren1, Ace, Agtr1a, Col3, and
Ctgf were found to be significantly increased in the IVF group com-
pared with those in the in vivo group (1.14-fold, P< 0.05; 2.15-fold,
P < 0.05; 2.01-fold, P < 0.05; 1.62-fold, P < 0.05; and 2.13-fold,
P < 0.05, respectively) (Figure 1A). No statistically significant dif-
ferences were observed in the expression levels of Ace2, Agt, Agtr1b,
Agtr2, Col1a1 and Col1a2 (P> 0.05) between the in vivo group and
the IVF group (Figure 1A). At 10 weeks of age, the expression levels
of Ace, Agt, Agtr1b, Agtr2, Col1a1, and Col3 were also found to be
significantly increased in the IVF group compared with those in the
in vivo group (1.74-fold, P < 0.05; 2.04-fold, P < 0.05; 1.79-fold,
P< 0.05; 2.08-fold, P< 0.05; and 1.62-fold, P< 0.05, respectively)
(Figure 1B). But no statistically significant differences were found
in the expression levels of Ren1, Ace2, Agtr1a, Col1a2, and Ctgf
(P > 0.05) between the in vivo group and the IVF group (Figure 1B).
When the mice reached the age of 1.5 years, the expression levels of
Ren1, Ace, Agtr1b, Col3, and Ctgf were still increased in the IVF
group compared with those in the in vivo group (2.37-fold, P< 0.01;
2.38-fold, P < 0.05; 1.68-fold, P < 0.05; 1.86-fold, P < 0.05; and
1.81-fold, P < 0.05, respectively) (Figure 1C). However, no signif-
icant differences were found in the expression levels of Ace2, Agt,
Agtr1a, Agtr2, Col1a1, and Col1a2 (P > 0.05) between the in vivo
group and the IVF group (Figure 1C).
The protein expression levels of genes in the RAS components
and corresponding effect genes were further assessed using quan-
titative western blotting (Figure 2). At 3 weeks of age, the ex-
pression levels of REN1, ACE, AGTR1, and CTGF were signifi-
cantly increased in the IVF group compared with the in vivo group
(1.11-fold, P < 0.05; 1.26-fold, P < 0.05; 1.79-fold, P < 0.05;
1.85-fold, P < 0.05, respectively) (Figure 2A). No significant dif-
ferences were found in expression levels of AGTR2 and COL3
(P > 0.05) (Figure 2A). At 10 weeks of age, the expression
levels of ACE were significantly increased in the IVF group compared
with the in vivo group (1.14-fold, P< 0.05) (Figure 2B). The protein
expression levels of AGTR1, AGTR2, and CTGF were not statisti-
cally different between the two groups at 10 weeks of age (P > 0.05)
(Figure 2B). In old age, the protein expression of ACE and AGTR1
was upregulated in the IVF group (1.13-fold, P < 0.05; 1.40-fold,
P < 0.05, respectively) (Figure 2C), but the protein expression levels
of REN1, AGTR2, CTGF, and COL3 were not significantly different
(P > 0.05) (Figure 2C).
The altered methylation levels of CpG island regions of
Col1a1 in IVF-conceived mice
Among the differentially expressed genes, there are CpG islands near
the promoters regions of Col1a1. Thus, Col1a1 were selected to
explore whether the methylation levels of CpG island regions of
Col1a1 would change in IVF-conceived mice (Figure 3). Targeted
bisulfite sequencing analysis was used to detect the methylation level
of each CpG site in the targeted gene. Using this method, we mea-
sured methylation levels of 14 CpG sites in Col1a1 target regions.
The schematic overview of the CpG island regions of the Col1a1
is shown in Figure 3A. No statistically significant differences were
observed in the mean DNA methylation level of Col1a1 between the
IVF and in vivo groups (Figure 3B). At 3 weeks of age, the methy-
lation level of the CpG site 4 of Col1a1 was significantly reduced in
the IVF group (P < 0.05). The methylation levels of CpG sites 6 and
8 of Col1a1 at 10 weeks and of CpG sites 1, 2, and 3 of Col1a1 at
1.5 years of age were significantly reduced in the IVF group
(P < 0.05). Only the methylation level of CpG site 7 at 3 weeks
of age in the IVF group was increased (P < 0.05) (Figure 3B).
MiRNAs were involved in the regulation of IVF-induced
abnormal cardiac gene expression
A microarray analysis was first used to detect the expression pro-
file of miRNA in myocardial tissue in the IVF-conceived and in
vivo groups at 1.5 years (Figure 4A). While some upregulated
miRNAs were observed, the present study focused on significantly
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FIGURE 4. (A) Heat map showing the hierarchical clustering of miRNAs in the in vivo and IVF groups at 1.5 years. (B–D) Expression of miR-100, miR-297, and
miR-758 was altered in the myocardial tissue of the IVF-conceived mice. The gene expression of miR-100, miR-297, and miR-758 at (B) 3 weeks, (C) 10 weeks, and
(D) 1.5 years. (E and F) Correlation between AGTR1 and miR-297a-3p detected using the luciferase reporter gene assay. (E) The pmiR-AGTR1-WT plasmid was
mutated in the miRNA-predicted target site and designated as pmiR-AGTR1-Mut. (F) Luciferase activity of AGTR1 3′UTR luciferase reporters was detected after
transfecting the recombinant vectors along with miR-297a-3p mimics or NC. Data concerning the relative concentrations of miR-100, miR-297, and miR-758were
normalized to U6 snRNA; the relative levels were calculated using the 2−CT method. The data are presented as mean ± standard error of the mean. ∗P < 0.05
and ∗∗P < 0.01, compared with the in vivo group; Student t-test (N, in vivo = 6, IVF = 6 in 3-week-old mice; N, in vivo = 6, IVF = 6 in 10-week-old mice; and N, in
vivo = 6, IVF = 6 in 1.5-year-old mice). The data of luciferase activity are presented as mean ± standard error of triplicate cell cultures. ∗P < 0.05 and ∗∗P < 0.01.
upregulated miR-100, miR-297, and miR-758. The miR-100, miR-
297, and miR-758 were predicted to interact with Col3a1, Agtr1a,
and Col1a2, respectively. Next, quantitative RT-PCR was used to
detect the expression of miR-100, miR-297, and miR-758 in my-
ocardium from the IVF-conceived and in vivo groups at 3 weeks,
10 weeks, and 1.5 years of age. At 3 weeks, the expression levels of
miR-100, miR-297, and miR-758 were not found to be significantly
altered between the two groups (P > 0.05) (Figure 4B), whereas
at 10 weeks, a significant increase in miR-100 and miR-758 was
observed in the IVF group compared with the in vivo group (4.24-
fold, P < 0.05 and 4.03-fold, P < 0.01, respectively) (Figure 4C). A
similar trend was found during old age; the expression levels of miR-
100, miR-297, and miR-758 were found to be significantly increased
in the IVF group (1.76-fold, P < 0.05; 2.04-fold, P < 0.05; and
2.52-fold, P < 0.05) (Figure 4D). To further verify the interaction
between Agtr1 and miR-297, this study performed luciferase activ-
ity assay to confirm the prediction (Figure 4E and F). The results of
the luciferase activity assay showed that miR-297a-3p mimic signif-
icantly modulated the luciferase activity of the pmiR-AGTR1-WT
vector. However, the luciferase activity of the pmiR-AGTR1-Mut
vector was not affected by the miR-297a-3p mimics. This evidence
indicated that miR-297a-3p directly targeted AGTR1 and regulated
its expression (Figure 4E and F).
Proliferation of H9c2 was promoted by miR-297
probably through regulating the expression of AGTR1
and CTGF
Because miR-297 was found to have an upregulation tendency in the
myocardial tissue of IVF-conceived mice compared with the in vivo
group, H9c2 cardiomyocytes were transfected with 100 nM miR-
297 mimic to increase their expression level of miR-297 (Figure 5A).
The expression of AGTR1 and CTGF did not change significantly
after 24 h of overexpression of miR-297. However, the protein ex-
pression of AGTR1 and CTGF in the miR-297 overexpression group
significantly increased after 48 h, indicating that miR-297 could in-
crease the expression of AGTR1 and further promote the expression
of CTGF protein.
To examine whether miR-297 affects cell proliferation in H9c2
cells, the H9c2 cells were treated with 100 nM miR-297 mimic
for 48 h. Cell proliferation was examined to detect EdU-positive
cells using flow cytometry and fluorescence microscopy. The flow
cytometry results showed that the overexpression of miR-297 was
able to promote cell proliferation (23.57% ± 0.30%) compared
with the control group (13.23% ± 1.95%; Figure 5B). Significantly,
more EdU-positive cells were observed in the miR-297 mimic
group (25.47% ± 2.74%) compared with the control group
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FIGURE 5. (A) The miR-297 promoted the expression of AGTR1 and CTGF in the proliferation of H9c2 cardiomyocytes. The H9c2 cells were transfected with
negative control (NC) or miR-297 mimic for 24 or 48 h. The western blot analysis was used to analyze the expression of AGTR1 and CTGF proteins. GAPDH
was the internal control. (B and C) miR-297 was involved in the regulation of the proliferation of cardiac H9c2 cells. The H9c2 cell proliferation assay using
flow cytometry (B) and laser confocal microscopy (C). The cells were transfected with miR-297 and negative control (NC) after 48 h. The data are presented as
mean ± standard error of the mean. ∗P < 0.05 and ∗∗P < 0.01, compared with the in vivo group; Student t-test.
(15.79% ± 1.43%; Figure 5C) using fluorescence microscope
imaging.
Discussion
Since it was initially proposed that conception via ART might be
linked to an increased risk of developing long-term cardiovascular
health issues, several studies have confirmed an altered cardiovas-
cular phenotype and elevated metabolic risk in children born fol-
lowing IVF [13, 14]. For example, investigations have shown that
IVF-conceived children have significantly higher blood pressure com-
pared with spontaneously conceived children [41–44], something
that has recently been supported by a meta-analysis of 2112 children
conceived by ART, where data showed that there was a slight, yet sta-
tistically significant, increase in blood pressure compared with nat-
urally conceived offspring [45]. Furthermore, Brenda et al. reported
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FIGURE 6. ART procedures affected the expression of RAS and epigenetic
modifications in the myocardium. Oocytes and embryos were exposed to
various nonphysiological factors during IVF, such as culture media, altered
pH, visible light, higher oxygen pressure, and reproductive hormones. These
factors might result in the increased expression of Agt, Agtr1, and other
genes in the RAS. CTGF is crucial in AT1-mediated intracellular signaling and
can promote the expression of COL1 and COL3. Moreover, it was suggested
that the changes in the expression of Col1a1 genes in IVF-conceived mice
might have been caused by the decreased methylation of CpG sites in these
genes. MiR-100, miR-297, and miR-758 might be involved in the regulation
of the expression of Col3a1, Agtr1a, and Col1a2. In particular, miR-297 could
promote the proliferation of cardiomyocytes by interacting with AGTR1.
that children conceived through ART showed cardiac and vascu-
lar remodeling during the fetal period that persisted in postnatal
life [13]. Another meta-analysis of 25,856 children conceived using
IVF/ICSI techniques showed an increased risk of developing congen-
ital heart defects compared with those conceived spontaneously [46].
Using an IVF mouse model, this study goes some significant way to
addressing the urgent need for us to better understand the under-
lying mechanisms influencing ART-induced cardiovascular dysfunc-
tion (Figure 6). Furthermore, we have clarified the long-term health
effects of an ART-induced compromised cardiovascular system in
mice from aged 3 weeks to 1.5 years.
Several studies have shown that structural and functional alter-
ations of the heart are mediated through stimulation of a local car-
diac RAS system in the cardiac tissue and large arteries. Data suggest
that the cardiac RAS may act in an autocrine or paracrine manner
by binding to AGTR1 [47, 48], an idea supported by evidence which
suggests that the cardiac RAS is activated at advanced stages of heart
failure in humans [47, 48]. Besides that, AGTR1 activation has an
important role in the development of load-induced cardiac hypertro-
phy, even without Ang II involvement [49, 50]. In this present study,
the mRNA expression level of Ace, Agtr1, and Col3 was significantly
increased in the myocardial tissue of IVF-conceived mice at 3 weeks
and 1.5 years of age when compared to their naturally mated coun-
terparts. These findings were reflected at the protein level, where
AGTR1 was elevated in the myocardium of IVF-conceived mice at
both 3 weeks and 1.5 years of age. These results might be applied
to human physiology, providing a potential explanation for the car-
diovascular alterations observed in ART-conceived children.
Based on the hypothesis of “developmental origins of health and
disease” put forward by Barker, adverse events during the fetal de-
velopment period can increase the risks of some adult diseases, in-
cluding cardiovascular disorders [4]. Thus, it is not unreasonable
to conclude that ART intervention during the periconception pe-
riod might induce a health risk in the resulting offspring. During
ART, specifically in vitro gamete manipulation and embryo system,
spermatozoa, oocytes, and embryos are exposed to various nonphys-
iological factors, such as culture media, altered pH [51], light [52,
53], higher oxygen pressure [54], increased concentration of repro-
ductive hormones [55], and mechanical injection or biopsy, all of
which contribute to an altered periconception environment [56]. In
addition to in vitro ART, a sub-optimal uterine environment fol-
lowing embryo transfer is thought to further influence the long-term
viability of offspring. Interestingly, factors that create an adverse
interuterine environment, including maternal high-salt diet, inflam-
mation, and dietary restriction, have also been shown to alter the
fetal and offspring RAS [57–60].
CTGF, an immediate response gene of the CCN (Cyr61, Ctgf,
Nov) family, is a critical cytokine in the pathophysiology of fibrosis
that upregulates COL1 and COL3 in cardiomyocytes [61]. CTGF
is essential in AGTR1-mediated intracellular signaling and can ac-
tivate cytokines, such as transforming growth factor-β, resulting in
myocardial remodeling, vascular fibrosis, endothelial dysfunction,
and atherosclerosis progress [62]. Increased plasma levels of CTGF
may be a marker of pulmonary arterial hypertension associated with
congenital heart disease [63]. An abnormal expression of COL1 and
COL3 in the embryonic period may affect the heart’s structural de-
velopment [25]. Sustained changes in the expression of COL1 and
COL3 in adulthood would further increase the risk of cardiovascu-
lar diseases, such as hypertension, arrhythmia, and cardiac hyper-
trophy, and enhance the process of cardiovascular fibrosis and re-
modeling [26]. The effects of ART on genome-wide changes in DNA
methylation levels have been confirmed by several studies [64–66].
For instance, ART-conceived mice showed arterial tissue endothelial
dysfunction and increased DNA methylation of the promoter of the
eNOS gene [15]. CpG islands are located in or near the promoter re-
gion of genes and hence, prevent transcription factors from binding,
thus preventing transcription [67]. At 3 weeks and 1.5 years of age,
the methylation levels of some CpG sites in Col1a1 were significantly
decreased in the IVF-conceived group, which might contribute to the
changes in genes expression of Col1a1.
In addition to DNA methylation and chromatin histone acetyla-
tion modification, accumulating studies have also shown noncoding
RNA to be involved in the epigenetic modification of growth and
development [68]. MiRNAs are small noncoding RNA molecules of
approximately 22–24 nucleotides that participate in the transcrip-
tional and posttranscriptional regulation of gene expression [69]. A
variety of miRNAs have been shown to regulate hypertension, coro-
nary heart disease, and glucose and lipid metabolism disorders [70,
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71]. In this study, miR-100, miR-297, and miR-758 were chosen
as candidate genes after miRNA database prediction indicated that
they interact with Col3a1, Agtr1a, and Col1a2, respectively. Previ-
ous studies have shown that plasma miR-100 is positively associated
with coronary plaque vulnerability [72] can inhibit angiogenesis [73]
and is involved in the development and growth of pancreatic can-
cer [74], while miR-297 is involved in septic shock [75]. In this
study, the luciferase assay was used to demonstrate that miR-297
targets AGTR1 and promotes the proliferation of cardiomyocytes
by regulating the expression of AGTR1 and CTGF. Moreover, the
expression of miR-297 was shown to promote the proliferation of
H9c2 cells in culture, which might also indicate a role for miR-297
in cardiac structural and functional abnormalities. In accordance
with the present results, previous studies have also demonstrated
that upregulation of miR-297 promotes cardiomyocyte hypertrophy
induced by Ang II [76]. The functions of the miR might be extensive
due to its ability to bind multiple molecules [77]. The miR-297 could
directly inhibit gene expression by targeting on the 3′UTR region of
mRNA [76]. In addition, miRs also indirectly affect the gene expres-
sion by regulating transcription factors, nuclear factor and binding
proteins which are closely related to gene expression [77]. The miRs
might also target important molecules acting on cellular signaling,
indirectly affecting gene expression [78]. Therefore, we speculated
that miR-297 may also interact with other regulatory factors in the
signaling pathway regulated by AGRT1, and other mechanisms need
to be explored in future studies.
Evidence presented in this manuscript indicates that the expres-
sions of RAS-associated gene and protein expression in myocardial
tissue have been changed in the myocardium of IVF-conceived mice.
Furthermore, modifications to DNA methylation and abnormal pat-
terns of expression of miRNAs may be involved in the regulations,
and thus the cardiovascular health of IVF-conceived fetuses and off-
spring. The application of an IVF mouse model has enabled us to
investigate the long-term health of ART offspring. Given that ART
is now widely utilized, it is important to further explore the exact
signaling pathways and genes involved in embryonic defects, associ-
ated with environmental factors, which manifest as clinical disorders
in the adult. These findings provide new and important insights into
the mechanisms which control the development of cardiovascular
disease and will allow us to develop tools to minimize ART-induced
cardiovascular dysfunction at the point of fetal origin and also as
the offspring progress into adulthood [79].
Supplementary data
Supplementary data are available at BIOLRE online.
Supplementary Figure S1. The mRNA relative expression of genes
in the RAS components and those related to myocardial remodel-
ing in myocardial tissue in male and female mice respectively from
the in vivo and IVF groups at (A) 3 weeks, (B) 10 weeks, and (C)
1.5 years. Ren1, Ace, Ace2, Agt, Agtr1a, Agtr1b, and Agtr2 were
critical elements in the RAS. Col1a1, Col1a2, and Col3 were the
major components of the extracellular matrix of the heart and also
crucial in the development of heart and myocardial remodeling. Ctgf
promotes the pathological process of fibrosis. The data are presented
as mean± standard error of the mean. The relative levels were calcu-
lated using the 2−CT method. ∗P< 0.05 and ∗∗P< 0.01, compared
with the in vivo group; Student t-test (N, in vivo = 6, IVF = 6 in
3-week-old mice; N, in vivo = 6, IVF = 6 in 10-week-old mice; and
N, in vivo = 6, IVF = 6 in 1.5-year-old mice).
Supplementary Figure S2. The mRNA relative expression of
genes in the RAS components and those related to myocardial re-
modeling in myocardial tissue between males and females within
the IVF and in vivo groups. Data are mean ± standard error of
mean. ∗P < 0.05, compared with the in vivo group (Student t-test).
(N = 6/group)
Supplementary Figure S3. Average DNA methylation levels for the
whole region of CpG islands and mean methylation levels for indi-
vidual CpG sites of DNA methyltransferases in heart samples from
the in vivo and IVF groups. Gene methylation levels of Dnmt1,
Dnmt3a, and Dnmt3b at (A) 3 weeks, (B) 10 weeks, and (C)
1.5 years of age. Data are mean± standard error of mean. ∗P< 0.05
and ∗∗P < 0.01, compared with the in vivo group (Student t-test).
(N = 6/group).
Supplementary Figure S4. The mRNA levels of imprinting genes in
the myocardial tissue of in vivo and IVF groups at (A) 3 weeks, (B)
10 weeks, and (C) 1.5 years of age. Data are mean ± standard error
of the mean; relative mRNA levels were calculated by the 2−CT
method. ∗P < 0.05 and ∗∗P < 0.01 compared with in vivo group;
Student t-test (N = 6/group).
Supplementary Figure S5. Organ coefficient of the heart in the in
vivo and IVF groups. ∗P < 0.05, compared with the in vivo group
(Student t- test).
Supplementary Table S1. Sequence of RT-PCR primers
Supplementary Table S2. Sequence of RT-PCR primers for miRNAs
Supplementary Table S3. List of antibodies used
Supplementary Table S4. Primer sequence of targeted bisulfite se-
quencing
Supplementary Table S5. The methylation rates at each site.
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